Your browser doesn't support javascript.
loading
Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group.
Mekahli, Djalila; Müller, Roman-Ulrich; Marlais, Matko; Wlodkowski, Tanja; Haeberle, Stefanie; de Argumedo, Marta López; Bergmann, Carsten; Breysem, Luc; Fladrowski, Carla; Henske, Elizabeth P; Janssens, Peter; Jouret, François; Kingswood, John Christopher; Lattouf, Jean-Baptiste; Lilien, Marc; Maleux, Geert; Rozenberg, Micaela; Siemer, Stefan; Devuyst, Olivier; Schaefer, Franz; Kwiatkowski, David J; Rouvière, Olivier; Bissler, John.
Affiliation
  • Mekahli D; PKD Research Group, Laboratory of Ion Channel Research, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. djalila.mekahli@uzleuven.be.
  • Müller RU; Department of Paediatric Nephrology, University Hospitals Leuven, Leuven, Belgium. djalila.mekahli@uzleuven.be.
  • Marlais M; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Wlodkowski T; CECAD, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Haeberle S; Center for Rare Diseases Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • de Argumedo ML; UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Bergmann C; Division of Paediatric Nephrology, Center for Paediatrics and Adolescent Medicine, University Hospital, Heidelberg, Germany.
  • Breysem L; Division of Paediatric Nephrology, Center for Paediatrics and Adolescent Medicine, University Hospital, Heidelberg, Germany.
  • Fladrowski C; Basque Office for Health Technology Assessment, (OSTEBA), Basque Government, Vitoria-Gasteiz, Spain.
  • Henske EP; Department of Medicine IV, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Janssens P; Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany.
  • Jouret F; Department of Radiology, University Hospital of Leuven, Leuven, Belgium.
  • Kingswood JC; Associazione Sclerosi Tuberosa ASP, Rome, Italy.
  • Lattouf JB; European Tuberous Sclerosis Complex Association (ETSC), Oestrich-Winkel, Germany.
  • Lilien M; Center for LAM Research and Clinical Care, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Maleux G; Department of Nephrology and Arterial Hypertension, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel, Brussels, Belgium.
  • Rozenberg M; Division of Nephrology, Department of Internal Medicine, University of Liège Hospital, Liège, Belgium.
  • Siemer S; Interdisciplinary Group of Applied Genoproteomics, Cardiovascular Sciences, University of Liège, Liège, Belgium.
  • Devuyst O; Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Centre, St Georges University of London, London, UK.
  • Schaefer F; Department of Surgery-Urology, CHUM-Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Kwiatkowski DJ; Department of Paediatric Nephrology, Wilhelmina Children´s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Rouvière O; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
  • Bissler J; European Tuberous Sclerosis Complex Association (ETSC), Oestrich-Winkel, Germany.
Nat Rev Nephrol ; 20(6): 402-420, 2024 06.
Article in En | MEDLINE | ID: mdl-38443710
ABSTRACT
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the presence of proliferative lesions throughout the body. Management of TSC is challenging because patients have a multifaceted systemic illness with prominent neurological and developmental impact as well as potentially severe kidney, heart and lung phenotypes; however, every organ system can be involved. Adequate care for patients with TSC requires a coordinated effort involving a multidisciplinary team of clinicians and support staff. This clinical practice recommendation was developed by nephrologists, urologists, paediatric radiologists, interventional radiologists, geneticists, pathologists, and patient and family group representatives, with a focus on TSC-associated kidney manifestations. Careful monitoring of kidney function and assessment of kidney structural lesions by imaging enable early interventions that can preserve kidney function through targeted approaches. Here, we summarize the current evidence and present recommendations for the multidisciplinary management of kidney involvement in TSC.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberous Sclerosis Limits: Humans Language: En Journal: Nat Rev Nephrol / Nature reviews. Nephrology (Online) Journal subject: NEFROLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberous Sclerosis Limits: Humans Language: En Journal: Nat Rev Nephrol / Nature reviews. Nephrology (Online) Journal subject: NEFROLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication: